Elsevier

Life Sciences

Volume 281, 15 September 2021, 119721
Life Sciences

The role of melatonin on radiation-induced pneumonitis and lung fibrosis: A systematic review

https://doi.org/10.1016/j.lfs.2021.119721Get rights and content

Abstract

Purpose

Pneumonitis and lung fibrosis, as the most common compliances of lung irradiation, can affect the quality of life. The use of radio-protective agents can ameliorate these injuries. This study aimed to review the potential protective role of melatonin in the treatment of radiation-induced Pneumonitis and lung fibrosis.

Methods

The current systematic study was conducted based on PRISMA guidelines to identify relevant literature on “ the effect of melatonin on radiation-induced pneumonitis and lung fibrosis” in the electronic databases of Web of Science, Embase, PubMed, and Scopus up to January 2021. Eighty-one articles were screened in accordance with the inclusion and exclusion criteria of the study. Finally, eight articles were included in this systematic review.

Results

The finding showed that the lung irradiation-induced pneumonitis and lung fibrosis. The co-treatment with melatonin could alleviate these compliances through its anti-oxidant and anti-inflammatory actions. Melatonin through upregulation of some enzymes such as catalase, superoxide dismutase, glutathione, NADPH oxidases 2 and 4, dual oxidases 1 and 2, and also downregulation of malondialdehyde reduced oxidative stress following lung radiation. Moreover, melatonin through its anti-inflammatory effects, can attenuate the increased levels of nuclear factor kappa B, tumor necrosis factor alpha, transforming growth factor beta 1, SMAD2, interleukin (IL)-4, IL-4 receptor-a1 (IL4ra1), and IL-1 beta following lung radiation. The histological damages induced by ionizing radiation were also alleviated by co-treatment with melatonin.

Conclusion

According to the obtained results, it was found that melatonin can have anti-pneumonitis and anti-fibrotic following lung irradiation.

Introduction

Cancer or malignant tumor is characterized as the uncontrolled growth of cells and is one of the leading causes of death worldwide [[1], [2], [3]]. Moreover, a more drastic increment in its incidence and mortality has been reported worldwide [4,5]. There are several therapeutic modalities for cancer treatment which can be used as systemic, local, or targeted therapies [[6], [7], [8]].

Radiotherapy, as a local cancer treatment (for most cases), is used in 50–70% of cancer patients during their therapeutic course [[9], [10], [11]]. There are several benefits to this therapeutic modality, including non-invasiveness, organ-preservation, cost-efficiency, and spatiotemporal flexibility in tumor targeting [[12], [13], [14]]. Despite its beneficial effects for cancer control, there are some concerns related to decreasing radiotherapeutic efficiency due to induce the acute and/or late adverse effects in normal organs/tissues [15]; as some complications can affect the quality of life of irradiated patients, resulting to decrease the cost-effectiveness of radiotherapy [16,17]. Even when radiotherapy is curative, the normal tissue complications lead to suffering long-term survivors [18]. In some cases, damage to normal tissues (particularly highly radiosensitive tissues) may stop the treatment course due to acute reactions or restrict to deliver the sufficient radiation dose to the tumor [19].

The lung is considered as an organ sensitive to ionizing radiation and late responding in the body [20]. Following the exposure of this radiosensitive organ to a high radiation dose, several cytokines and chemokines are released which lead to the infiltration of inflammatory cells [21]. In addition, macrophages, neutrophils, and are able to release several cytokines which result to mediate that result in mediating the appearance of edema and pneumonitis [22]. Furthermore, chronic production of free radicals, including reactive oxygen species (ROS) and reactive nitrogen species (RNS) leads to stimulate collagen deposition in extracellular space, inducing fibrosis [23]. Both pneumonitis and lung fibrosis can lead the irradiated person to death [24]. Therefore, special attention should be considered to minimize damage to the lung tissue and effectively deliver the radiation dose to the tumor. Some studies have been performed to alleviate radiation-induced pneumonitis and fibrosis. In this regard, neutralization of free radicals, attenuation of pro-oxidant and pro-inflammatory mediators induced by ionizing radiation has been proposed for protection against pneumonitis and fibrosis [25]. Or, the use of agents such as captopril and flaxseed which are able to suppress renin-angiotensin system and oxidative stress can attenuate the signs related to pneumonitis and fibrosis [26,27].

In the past several decades, the use of radio-protector and/or radio-sensitizer agents for the alleviation of radiation-induced adverse effects has attracted much attention. Melatonin, as an indole-derived hormone, is mainly generated and secreted by the pineal gland. This hormone has various impacts on the normal tissues such as anti-oxidant, anti-inflammatory, and anti-apoptotic effects; hence, it can protect the normal tissues against oxidative and inflammatory damage [[28], [29], [30]]. Briefly, melatonin exerts an anti-oxidative action via two mechanisms of direct and indirect. In the direct pathway, this agent mostly exerts its anti-oxidant effect via radical adduct formation, single electron transfer, and hydrogen transfer [31,32]. In the indirect pathway, melatonin can stimulate anti-oxidant enzymes, protect anti-oxidant enzymes against oxidative damage, modulate genomic expressions, and so on [33,34]. Additionally, melatonin can markedly decrease pro-apoptotic factors and also increase anti-apoptotic factors [35]. The anti-inflammatory effect of melatonin is exerted by modulation of inflammatory cytokine expression levels, inflammatory mediators, infiltration of inflammatory cells, etc. [29,36].

A systematic search was performed on the potential protective role of melatonin on radiation-induced pneumonitis and lung fibrosis in the current study. Furthermore, we tried to discuss: 1) the mechanisms underlying radiation-induced pneumonitis and lung fibrosis, and 2) the mechanisms related to the radio-preventive role of melatonin.

Section snippets

Search strategy

In the present study, we performed a systematic search in accordance with the guideline of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [37]. The literature search was carried out to assessed all relevant studies on “the role of melatonin on radiation-induced pneumonitis and lung fibrosis” in both medical subject heading (MeSH) or advance on electronic databases of Web of Science (WOS), Embase, PubMed, and Scopus up to January 2021 using the keywords of

Literature search and screening

Fig. 1 is shown the process of study selection.

A systematic search found Eighty-one articles on the above-mentioned electronic databases up to January 2021. After removing the duplicated articles (n = 41), the remaining ones (n = 40) were screened in titles and abstracts, and 29 of them were omitted. Eleven articles were qualified for assessment of their full-texts. Considering the inclusion and exclusion criteria, eight articles were included in the current systematic review. Table 1

Discussion

In the present study, the potential protective effects of melatonin on radiation-induced pneumonitis and lung fibrosis were systematically reviewed. The obtained results have been represented in Table 1. Additionally, some of the important alterations following lung irradiation as well as the effects of melatonin on these changes are shown in Fig. 2.

The irradiation of the lungs (as radiosensitive organs) during radiotherapy of thorax and chest wall tumors is inevitable [46,47]. The extent of

Perspective of future research

Pneumonitis and lung fibrosis are the most common compliances of lung irradiation to high doses. These adverse effects induced by ionizing radiation can affect life quality and lead to irradiated patients' death. In this regard, researchers have suggested that the use of radio-protective agents can ameliorate radiation-induced lung injuries. The results of some in-vivo and in-vitro studies have revealed that melatonin, via anti-oxidant and anti-inflammatory actions, is able to alleviate

Conclusion

Lungs are organs sensitive to ionizing radiation and lung irradiation can induce the injuries such as pneumonitis and lung fibrosis. The pre/post-treatment with melatonin could alleviate the radiation-induced pneumonitis and lung fibrosis through its anti-oxidant and anti-inflammatory effects. Melatonin through upregulation of some enzymes such as catalase, SOD, GSH, NOX2, NOX4, DUOX1, and DUOX2 and downregulation of MDA reduced oxidative stress following lung irradiation. Moreover, melatonin

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

CRediT authorship contribution statement

S.Sh. and T.A. gave the idea and drafted some parts of the manuscript. RA-F., A.B. and M.D-G did the literature search and drafted figures. H.Z., Gh.A. and M.M. drafted some parts of the manuscript. B.F. gave the idea, edited the manuscript, and supervised the whole study. All authors read and approved the manuscript.

Declaration of competing interest

The authors declare that there are no conflicts of interest.

References (88)

  • L.B. Marks et al.

    Radiation-induced lung injury

    Semin. Radiat. Oncol.

    (2003)
  • J. Yarnold et al.

    Pathogenetic mechanisms in radiation fibrosis

    Radiother. Oncol.

    (2010)
  • M. Redza-Dutordoir et al.

    Activation of apoptosis signalling pathways by reactive oxygen species

    Biochim. Biophys. Acta

    (2016)
  • H. Edvardsen et al.

    SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling

    Int. J. Radiat. Oncol. Biol. Phys.

    (2013)
  • H. Bahig et al.

    Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease

    Pract. Radiat. Oncol.

    (2016)
  • Y. Chen et al.

    Radiation pneumonitis and early circulatory cytokine markers

    Semin. Radiat. Oncol.

    (2002)
  • A.-K. Min et al.

    Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-β signaling pathway

    Biochem. Biophys. Res. Commun.

    (2010)
  • K. Mortezaee et al.

    Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review

    Life Sci

    (2019)
  • M. Martin et al.

    TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?

    Int. J. Radiat. Oncol. Biol. Phys.

    (2000)
  • B. Farhood et al.

    TGF-β in radiotherapy: mechanisms of tumor resistance and normal tissues injury

    Pharmacol. Res.

    (2020)
  • B. Farhood et al.

    Incidence and mortality of various cancers in Iran and compare to other countries: a review article

    Iran. J. Public Health

    (2018)
  • N. Abdi Goushbolagh et al.

    Estimation of radiation dose-reduction factor for cerium oxide nanoparticles in MRC-5 human lung fibroblastic cells and MCF-7 breast-cancer cells

    Artif. Cells Nanomed. Biotechnol .

    (2018)
  • F. Bray et al.

    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    CA Cancer J. Clin.

    (2018)
  • N.A. Goushbolagh et al.

    Quantitative cytotoxicity, cellular uptake and radioprotection effect of cerium oxide nanoparticles in MRC-5 normal cells and MCF-7 cancerous cells

    BioNanoScience

    (2018)
  • N. Abdi Goushbolagh et al.

    Photosensitizer effects of MWCNTs-COOH particles on CT26 fibroblastic cells exposed to laser irradiation

    Artif. Cells Nanomed. Biotechnol.

    (2019)
  • A.-M. Tsimberidou

    Targeted therapy in cancer

    Cancer Chemother. Pharmacol.

    (2015)
  • R. Baskar et al.

    Cancer and radiation therapy: current advances and future directions

    Int. J. Med. Sci.

    (2012)
  • G.-O. Ahn et al.

    Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives

    Cell Cycle

    (2009)
  • S.R. Mahdavi et al.

    Measurement of peripheral dose to the pelvic region and the associated risk for cancer development after breast intraoperative electron radiation therapy

    J. Radiol. Prot.

    (2019)
  • J. Thariat et al.

    Past, present, and future of radiotherapy for the benefit of patients

    Nat. Rev. Clin. Oncol.

    (2013)
  • A. Razzaghdoust et al.

    Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy

    Strahlenther. Onkol.

    (2014)
  • A. Saadipoor et al.

    Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy

    Phytother. Res.

    (2019)
  • S.-H. Ryu et al.

    Protective effect of α-lipoic acid against radiation-induced fibrosis in mice

    Oncotarget

    (2016)
  • J.H. Kim et al.

    Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials

    Radiat. Oncol. J.

    (2014)
  • R. Yahyapour et al.

    Protective effect of metformin, resveratrol and alpha-lipoic acid on radiation-induced pneumonitis and fibrosis: a histopathological study

    Curr. Drug Res. Rev.

    (2019)
  • M. Medhora et al.

    Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors

    Respirology

    (2012)
  • W. Zhao et al.

    Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications

    Curr. Med. Chem.

    (2009)
  • J.R. Carver et al.

    American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects

    J. Clin. Oncol.

    (2007)
  • D. Citrin et al.

    Radioprotectors and mitigators of radiation-induced normal tissue injury

    Oncologist

    (2010)
  • E.P. Cohen et al.

    Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy

    Curr. Drug Targets

    (2010)
  • R. Pietrofesa et al.

    Radiation mitigating properties of the lignan component in flaxseed

    BMC Cancer

    (2013)
  • H. Haghi-Aminjan et al.

    The role of melatonin on chemotherapy-induced reproductive toxicity

    J. Pharm. Pharmacol.

    (2018)
  • H. Haghi-Aminjan et al.

    The protective role of melatonin in chemotherapy-induced nephrotoxicity: a systematic review of non-clinical studies

    Expert Opin. Drug Metab. Toxicol.

    (2018)
  • M. Najafi et al.

    The melatonin immunomodulatory actions in radiotherapy

    Biophys. Rev.

    (2017)
  • Cited by (0)

    1

    The first and second authors have the first (similar) positions.

    View full text